Literature DB >> 15982391

How mammillary fistulas should be managed.

Satheesha Hanavadi1, Gordon Pereira, Robert E Mansel.   

Abstract

Mammillary fistulas are uncommon, but when they occur they cause prolonged morbidity. The etiology and management strategies are less well established. The purpose of this study is to evaluate the etiologic factors and assess the results of surgical treatment. It is a retrospective study of all patients treated for mammillary fistula from 1990 to 2001. The clinical data, including complications of surgical treatment, were collected from medical records. Fistulas were segregated into simple and complex fistulas before analyzing the results of surgical treatment. Thirty-five patients were treated during this period. A history of either drainage of a subareolar abscess or spontaneous rupture of an inflammatory mass preceded the development of mammillary fistula in the majority of patients. Previous Hadfield's procedure for duct ectasia contributed to the development of fistula in seven patients. Seventeen patients presented with simple fistula. A large proportion of them were treated by total duct excision in recent years, with a higher rate of recurrence (4/6). Eighteen patients presented with complex fistulas; two of them had recurrences following surgical treatment. The overall recurrence rate was 23%. The majority of the patients showed features of periductal mastitis on histologic examination. Postoperative wound infection was positively associated with fistula recurrence. The best management of mammillary fistula remains a problem. Simple fistulas should be treated by fistulectomy and primary closure. Total duct excision should be reserved for complex fistulas. Postoperative wound infection is also a major factor in fistula recurrence. All patients should receive antibiotics. Surgery for duct ectasia has caused fistulas in 20% of cases in our study, raising the issue of restricting total duct excision to more severe forms of the disease. Mammillary fistulas should be treated more appropriately in a specialized breast unit with particular interest in benign breast disease.

Entities:  

Mesh:

Year:  2005        PMID: 15982391     DOI: 10.1111/j.1075-122X.2005.21641.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  6 in total

Review 1.  Benign Breast Disease in Women.

Authors:  Angrit Stachs; Johannes Stubert; Toralf Reimer; Steffi Hartmann
Journal:  Dtsch Arztebl Int       Date:  2019-08-09       Impact factor: 5.594

2.  Duct Ectasia and Periductal Mastitis in Indian Women.

Authors:  Kirithiga Ramalingam; Anurag Srivastava; Seenu Vuthaluru; Anita Dhar; Rama Chaudhry
Journal:  Indian J Surg       Date:  2014-05-08       Impact factor: 0.656

3.  Treatments for Periductal Mastitis: Systematic Review and Meta-Analysis.

Authors:  Huiying Xu; Ruidong Liu; Yanli Lv; Zhenhua Fan; Weimin Mu; Qingzhong Yang; Hui Fu; Yi Li
Journal:  Breast Care (Basel)       Date:  2021-02-18       Impact factor: 2.860

Review 4.  Current Understanding and Management of Plasma Cell Mastitis: Can We Benefit from What We Know?

Authors:  Mengying Xing; Shichang Zhang; Xiaoming Zha; Jiexin Zhang
Journal:  Breast Care (Basel)       Date:  2021-10-06       Impact factor: 2.268

5.  Sonographically guided triamcinolone injection for the treatment of chronic post-operative mammillary fistula.

Authors:  J D Berná-Serna; J D Berná-Mestre; A Piñero
Journal:  Br J Radiol       Date:  2012-12       Impact factor: 3.039

6.  Male Zuska's disease.

Authors:  Shepard P Johnson; Christodoulos Kaoutzanis; George A Schaub
Journal:  BMJ Case Rep       Date:  2014-04-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.